跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MC3-LNP
首页
药物
MC3-LNP
MC3-LNP
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Preparation and application of lung targeting LNP based on cationic lipopeptide
申请人: UNIV CHINA PHARMA
优先权: 2025
CN
SUGAR-CONJUGATED LIPID NANOPARTICLES FOR TARGETED DELIVERY OF SIRNA TO HEPATOCYTES
申请人: UNIV VIRGINIA PATENT FOUNDATION
优先权: 2023
US
WO
2 件公开
Novel coronavirus mRNA vaccine and preparation method thereof
申请人: NINGBO RONGAN BIOLOGICAL PHARMACEUTICAL CO LTD
优先权: 2023
CN
CD19-CAR-mRNA-LNP particle as well as preparation method and application thereof
申请人: UNION HOSPITAL TONGJI MEDICAL COLLEGE HUAZHONG UNIV SCI & TECH
优先权: 2023
CN
Glucoside sterol component lipid nanoparticle for regulating mRNA transfection as well as preparation method and application of glycoside sterol component lipid nanoparticle
申请人: UNIV BEIJING CHEM TECH
优先权: 2025
CN
Ginsenoside nucleic acid-based lipid nanoparticles as well as preparation method and application thereof
申请人: UNIV SHANDONG
优先权: 2023
CN
可电离的含杂环脂质分子及其在制备脂质纳米粒的应用
申请人: 南京吉迈生物技术有限公司
优先权: 2022
CN
Gene delivery ionizable lipid-based injectable microsphere as well as preparation method and application thereof
申请人: RUIJIN HOSPITAL SHANGHAI JIAOTONG UNIV SCHOOL MEDICINE
优先权: 2025
CN
药物
反馈